The institutional landscape for SAB Biotherapeutics, Inc. (NASDAQ:SABS) includes 34 filers as of the latest reporting cycle ending September 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 30 Sep, 2025 | 11,420,000 | 11,420,000 | 0.00% | $22,954,200.00 |
| RA CAPITAL MANAGEMENT, L.P. | 30 Sep, 2025 | 4,401,500 | 2,027,419 | 85.40% | $8,847,015.00 |
| Commodore Capital LP | 30 Sep, 2025 | 4,401,500 | 4,218,326 | 2,302.91% | $8,847,015.00 |
| Woodline Partners LP | 30 Sep, 2025 | 2,850,881 | 2,850,881 | 0.00% | $5,730,271.00 |
| Sessa Capital IM, L.P. | 30 Sep, 2025 | 2,198,457 | 1,740,000 | 379.53% | $4,418,899.00 |
| BVF INC/IL | 30 Sep, 2025 | 932,697 | 14,871 | 1.62% | $1,874,721.00 |
| SPHERA FUNDS MANAGEMENT LTD. | 30 Sep, 2025 | 566,395 | 566,395 | 0.00% | $1,138,454.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 365,753 | 83,382 | 29.53% | $735,163.00 |
| HB Wealth Management, LLC | 30 Sep, 2025 | 307,500 | 44,300 | 16.83% | $618,075.00 |
| AWM Investment Company, Inc. | 30 Sep, 2025 | 200,000 | 200,000 | 0.00% | $402,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 85,718 | 946 | 1.12% | $172,317.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 80,840 | 69,810 | 632.91% | $162,488.00 |
| Pathstone Holdings, LLC | 30 Sep, 2025 | 50,650 | 0 | 0.00% | $101,807.00 |
| Virtu Financial LLC | 30 Sep, 2025 | 19,982 | 19,982 | 0.00% | $40.00 |
| Kovitz Investment Group Partners, LLC | 30 Sep, 2025 | 19,201 | 0 | 0.00% | $38,594.00 |
| First PREMIER Bank | 30 Sep, 2025 | 18,986 | 0 | 0.00% | $38.00 |
| DIMENSIONAL FUND ADVISORS LP | 30 Sep, 2025 | 15,781 | 15,781 | 0.00% | $31,720.00 |
| ADAR1 Capital Management, LLC | 30 Sep, 2025 | 15,000 | 15,000 | 0.00% | $30,150.00 |
| UBS Group AG | 30 Sep, 2025 | 13,221 | 2,563 | 24.05% | $26,574.00 |
| Kestra Advisory Services, LLC | 30 Sep, 2025 | 11,930 | 0 | 0.00% | $23,979.00 |